Skip to content

The effects of the synbiotic Ecologic 825/scFOS on intestinal barrier function and immune modulation

The effects of the synbiotic Ecologic 825/scFOS on intestinal barrier function and immune modulation - Effects of synbioticum on intestinal barrier function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON38875
Enrollment
20
Registered
2013-08-26
Start date
2013-11-20
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal symptoms

Interventions

Positioning of a feeding catheter, to be applied for fluid sampling from the small intestine. Blood sampling. Sugar test (consumption of sugar drink and collection of urine) for the assewssment of i

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: no gastrointestinal complaints age between 18 and 65 yrs BMI between 20 and 30 kg/m^2

Exclusion criteria

Exclusion criteria: Use of medication within 14 days prior to testing Administration of probiotics, investigational drugs, or participation in a scientific intervention study in the 180 days prior to testing Use of antibiotics in the 90 days prior to testing women; pregnancy

Design outcomes

Primary

MeasureTime frame
• Sugar recovery in urine, as indicator of intestinal permeability

Secondary

MeasureTime frame
- Measurements in blood at baseline and after the supplementation period • Biomarkers of immune modulation; plasma levels of TNFa, IL-1b, IL-6, IL-8, IL-17, MCP-1 and MIP-1a - Measurements in small intestinal fluid (duodenum/jejunum/ileum) and feces • Relative abundance of CRIB • Microbial diversity and population dynamics • In situ gene expression of the microbiota - Questionnaire at baseline, during and after the supplementation period • The symptom diary

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)